2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease

Q3 Medicine JVS-vascular science Pub Date : 2023-01-01 DOI:10.1016/j.jvssci.2023.100117
Carly Thaxton MD , Katherine Gallagher MD , Alan Dardik MD, PhD
{"title":"2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease","authors":"Carly Thaxton MD ,&nbsp;Katherine Gallagher MD ,&nbsp;Alan Dardik MD, PhD","doi":"10.1016/j.jvssci.2023.100117","DOIUrl":null,"url":null,"abstract":"<div><p>The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to facilitate the exchange of basic and translational science to stimulate and inspire participants to study and find solutions to vascular conditions. The theme of the conference this year was “Structural and Immune Cells in Vascular Disease.” Abstract sessions focused on venous disease, vascular regeneration, stem cells and wound healing, aortopathies, and the role of the immune system in atherosclerosis. A moderated translational science panel included talks from Dr Chiara Giannarelli and Dr Bhama Ramkhelawon. Recipients of Society for Vascular Surgery partner grants and National Institutes of Health K08 awardees presented their progress reports, and the Resident Research and VRIC Trainee Awardees were acknowledged. The Alexander W. Clowes Distinguished Lecture, entitled “Co-stimulatory Immune Checkpoints in Atherosclerosis: Novel Immunotherapeutic Targets to Combat Atherosclerotic Cardiovascular Disease” was given by Dr Ester Lutgens. VRIC continues to foster interdisciplinary collaborations across the translational field of vascular disease.</p></div>","PeriodicalId":74035,"journal":{"name":"JVS-vascular science","volume":"4 ","pages":"Article 100117"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/ec/main.PMC10463243.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JVS-vascular science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666350323000214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to facilitate the exchange of basic and translational science to stimulate and inspire participants to study and find solutions to vascular conditions. The theme of the conference this year was “Structural and Immune Cells in Vascular Disease.” Abstract sessions focused on venous disease, vascular regeneration, stem cells and wound healing, aortopathies, and the role of the immune system in atherosclerosis. A moderated translational science panel included talks from Dr Chiara Giannarelli and Dr Bhama Ramkhelawon. Recipients of Society for Vascular Surgery partner grants and National Institutes of Health K08 awardees presented their progress reports, and the Resident Research and VRIC Trainee Awardees were acknowledged. The Alexander W. Clowes Distinguished Lecture, entitled “Co-stimulatory Immune Checkpoints in Atherosclerosis: Novel Immunotherapeutic Targets to Combat Atherosclerotic Cardiovascular Disease” was given by Dr Ester Lutgens. VRIC continues to foster interdisciplinary collaborations across the translational field of vascular disease.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2023年血管研究倡议会议:血管疾病中的结构和免疫细胞
2023年血管研究倡议会议(VRIC)在马萨诸塞州波士顿举行,恰逢美国心脏协会主办的2023年发现血管的第一天。VRIC将血管临床医生、外科医生科学家和基础科学研究人员吸引到一个共同的舞台上,促进基础科学和转化科学的交流,以激励和激励参与者研究并找到血管疾病的解决方案。今年会议的主题是“血管疾病中的结构和免疫细胞”。摘要会议聚焦于静脉疾病、血管再生、干细胞和伤口愈合、主动脉病变以及免疫系统在动脉粥样硬化中的作用。主持的翻译科学小组包括Chiara Giannarelli博士和Bhama Ramkhelawon博士的演讲。血管外科学会合作伙伴奖获得者和美国国立卫生研究院K08奖获得者提交了他们的进度报告,住院研究和VRIC实习生奖获得者获得了表彰。Alexander W.Clowes杰出演讲题为“动脉粥样硬化中的共刺激免疫检查点:对抗动脉粥样硬化性心血管疾病的新免疫治疗靶点”,由Ester Lutgens博士主讲。VRIC继续促进血管疾病转化领域的跨学科合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.20
自引率
0.00%
发文量
0
审稿时长
28 weeks
期刊最新文献
Toll-Like Receptor 4, a potential therapeutic target of lower limb ischemic myopathy that raises further questions Role of Toll-like Receptor 4 in Skeletal Muscle Damage in Chronic Limb Threatening Ischaemia Predicting Future Occlusion or Stenosis of Lower Extremity Bypass Grafts Using Artificial Intelligence to Simultaneously Analyze All Flow Velocities Collected in Current and Previous Ultrasound Exams A central arteriovenous fistula reduces systemic hypertension in a mouse model Systematic review and meta-analysis of the genetics of peripheral arterial disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1